Poor Ovarian Response (POR) represents one of the most significant and pervasive challenges facing modern assisted reproductive technology (ART). For couples embarking on in vitro fertilization (IVF), a diagnosis of POR characterized by an inadequate ovarian response to standard gonadotropin (GN) stimulation can drastically reduce success rates. Approximately 15–20% of women undergoing IVF experience POR.

For decades, the specific underlying cause, or etiology, of POR has remained poorly understood. However, recent advancements in cellular biology and bioinformatics are illuminating the complex mechanisms governing ovarian health, pointing directly to how fundamental processes of cell energy and cell death influence fertility outcomes. New research focuses on the intricate interplay between mitochondrial metabolism (the core of cell energy) and ferroptosis (a specific form of cell death) in the granulosa cells (GCs) that nurture developing eggs. Understanding this molecular crosstalk is now offering novel pathways for diagnosis and targeted therapeutic strategies.

The Enigma of Poor Ovarian Response (POR)

Poor Ovarian Response is generally defined by a suboptimal output of follicles during controlled ovarian stimulation. Clinically, women are often diagnosed according to specific criteria, such as the POSEIDON criteria, which might classify a woman younger than 35 years old as having POR if she develops fewer than four mature follicles (diameter < 15 mm) on the day of human chorionic gonadotropin (hCG) administration.

POR shares similarities with premature ovarian insufficiency (POI), suggesting a potentially common pathogenesis. While known causes of POI include genetic mutations, immune or metabolic disorders, and environmental toxins, nearly 90% of POI cases are classified as idiopathic, making the pathogenic relationship between POR and POI unclear. Given the lack of practical methods to prevent or effectively treat POR currently, exploring its underlying mechanisms is an urgent necessity

Cellular Health: The Interdependent Roles of Energy and Death

The health and function of the ovary are inextricably linked to the vitality of its cells, particularly the oocytes (eggs) and the surrounding granulosa cells (GCs). Two critical cellular processes are now recognized as central to maintaining this vitality: mitochondrial metabolism and ferroptosis.

1.Mitochondrial Metabolism: The Engine of Fertility

Mitochondria are universally known as the powerhouses of the cell, primarily responsible for generating ATP through oxidative phosphorylation. Beyond energy production, they play crucial roles in programmed cell death and calcium homeostasis.

• Ovarian Aging and Dysfunction: Previous studies have established a strong correlation between ovarian aging and mitochondrial dysfunction.
• Energy Deficits and Stress: Conditions such as decreased oxidative phosphorylation activity, reduced ATP production, and elevated levels of reactive oxygen species (ROS) in oocytes are directly associated with POI.
• The Protective Role: Properly functioning mitochondria are essential for preventing infertility and ovarian dysfunction. Research suggests that inhibiting the excessive activation of mitophagy (the self-cleaning process of mitochondria) can prevent mitochondrial damage and improve ovarian function.

2. Ferroptosis: Iron-Dependent Programmed Cell Death

Ferroptosis is a distinct type of programmed cell death characterized by iron dependency and lipid peroxidation. Recent evidence suggests that ferroptosis closely impacts ovarian reserve, often through mechanisms involving oxidative stress and lipid peroxidation.

• GC Vulnerability: Granulosa cells, which closely surround oocytes and are critical for normal oocyte development via bidirectional interactions, are highly vulnerable. Studies have shown that hydrogen peroxide (H2O2) can induce oxidative stress damage and ferroptosis in human ovarian granulosa cells.
• Mitochondrial Crosstalk: Crucially, ferroptosis and mitochondrial function are tightly linked. Mitochondrial dysfunction and damage can significantly promote oxidative stress, subsequently leading to the induction of ferroptosis. This synergistic relationship where an imbalance disrupts intracellular homeostasis underscores why GCs dysfunction in POR patients contributes to an unfavorable microenvironment for oocyte growth and maturation.
  

Identifying the Molecular Fingerprints of POR

To pinpoint the molecular mechanisms linking cell energy and cell death to POR, recent high-throughput studies have analyzed the transcriptome sequencing data of ovarian granulosa cell samples from POR patients versus healthy controls. The aim was to explore the role of ferroptosis-related genes (FRGs) and mitochondrial metabolism-related genes (MMRGs).

The Biomarker Discovery Process

Through sophisticated bioinformatics techniques, including differential expression analysis, consensus clustering, machine learning algorithms such as LASSO (Least Absolute Shrinkage and Selection Operator), and SVM-RFE (Support Vector Machine Recursive Feature Elimination), researchers honed in on key candidate genes.

The Path Ahead

While these findings are significant, several limitations must be addressed to translate this research into clinical reality.

• Sample Size and Generalizability: The initial study utilized a relatively small sample size, which requires future large-scale, multicenter, and prospective studies to enhance the generalizability and accuracy of the predictive models.
• Protein Validation: A critical next step is the validation of the findings at the protein level using techniques such as Western blotting, as mRNA expression does not always perfectly correlate with protein levels.
• Mechanism Elucidation: Comprehensive understanding requires integrating molecular, cellular, and animal experiments to fully map the specific regulatory mechanisms of mitochondrial metabolism-related genes (MMRGs) and ferroptosis-related genes (FRGs) in POR development.

In summary, by drawing a clear link between compromised cell energy (mitochondrial dysfunction) and programmed cell death (ferroptosis) in ovarian granulosa cells, researchers have provided the first comprehensive report studying these processes in POR. The identification of PLA2G4B and PRKCG as reliable biomarkers offers not only novel diagnostic tools but also promising targets for pharmacological interventions, such as enzastaurin and dirithromycin, signaling a new era in the prevention and treatment of this challenging fertility condition.